Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1263-1271
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1263
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1263
Table 1 Clinical characteristics of study participates by quartiles of hemoglobin A1c
Variables | HbA1c quartiles | P value | |||
Q1 (< 7.875), n = 32 | Q2 (7.875-9.050), n = 33 | Q3 (9.050-11.200), n = 32 | Q4 (≥ 11.200), n = 33 | ||
Age (yr) | 63.5 ± 13.3 | 60.9 ± 9.7 | 59.5 ± 16.1 | 60.2 ± 13.0 | 0.640 |
Sex (male/female) | 18/14 (56.3/43.8) | 16/17 (48.5/51.5) | 20/12 (62.5/37.5) | 21/12 (63.6/36.4) | 0.582 |
Diabetes duration (yr) | 6.5 (3.0, 17.5) | 10 (6.5, 15.0) | 8.0 (1.3, 19.8) | 5.0 (1.0, 12.0) | 0.173 |
Height (cm) | 165.6 ± 8.1 | 164.2 ± 8.8 | 166.8 ± 9.0 | 167.4 ± 6.6 | 0.392 |
Weight (cm) | 71.5 ± 11.5 | 70.9 ± 11.4 | 73.8 ± 18.3 | 71.4 ± 8.7 | 0.803 |
BMI (kg/m2) | 26.1 ± 3.7 | 26.2 ± 3.3 | 26.2 ± 4.5 | 25.4 ± 2.5 | 0.772 |
Neck line (cm) | 39.1 ± 3.5 | 38.2 ± 3.8 | 38.3 ± 4.0 | 38.4 ± 2.4 | 0.731 |
Waist line (cm) | 97.3 ± 8.9 | 95.0 ± 10.2 | 94.5 ± 11.1 | 94.7 ± 8.5 | 0.646 |
Hip line (cm) | 103.5 ± 8.3 | 102.1 ± 8.8 | 100.3 ± 9.7 | 100.9 ± 8.7 | 0.492 |
WHR | 0.94 ± 0.05 | 0.93 ± 0.04 | 0.94 ± 0.05 | 0.94 ± 0.04 | 0.698 |
SBP (mmHg) | 132.8 ± 21.2 | 139.1 ± 17.5 | 132.6 ± 20.3 | 134.3 ± 16.2 | 0.474 |
DBP (mmHg) | 77.2 ± 9.0 | 80.0 ± 8.2 | 78.3 ± 9.0 | 80.3 ± 8.0 | 0.415 |
mALB (g/L) | 11.0 (11.0, 41.5) | 11.0 (10.5, 50.0) | 32.5 (12.0, 123.5) | 20.0 (12.5, 53.5) | 0.031 |
TC (mmol/L) | 4.46 ± 1.01 | 4.70 ± 1.11 | 4.81 ± 1.29 | 5.00 ± 1.35 | 0.321 |
TG (mmol/L) | 1.54 (1.04, 2.32) | 2.17 (1.10, 2.93) | 1.81 (1.37, 3.83) | 1.37 (0.84, 2.28) | 0.044 |
HDL-C (mmol/L) | 1.25 ± 0.37 | 1.11 ± 0.32 | 1.10 ± 0.31 | 1.14 ± 0.31 | 0.274 |
LDL-C (mmol/L) | 2.83 ± 1.10 | 3.02 ± 1.02 | 2.89 ± 0.88 | 3.51 ± 1.15 | 0.037 |
HOMA-IR | 3.09 (1.69, 4.48) | 4.59 (3.07, 7.12) | 6.05 (4.34, 10.41) | 6.06 (3.62, 8.14) | < 0.001 |
HOMA-β | 80.15 (35.79, 131.06) | 38.55 (21.90, 73.18) | 53.04 (22.48, 96.73) | 21.70 (10.86, 45.92) | 0.001 |
Complicated with hypertension (%) | 17 (53.1) | 21 (63.6) | 17 (53.1) | 18 (54.5) | 0.796 |
Complicated with CHD (%) | 20 (62.5) | 18 (54.5) | 23 (71.9) | 18 (54.5) | 0.429 |
- Citation: Gao XY, Zhou CX, Li HM, Cheng M, Chen D, Li ZY, Feng B, Song J. Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes. World J Diabetes 2024; 15(6): 1263-1271
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1263.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1263